title: Assessment of insulin-like growth factors and mutagen sensitivity as predictors of lung cancer risk.
authors.affiliation: Department of Epidemiology, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
authors.forename: Xifeng
authors.initials: X
authors.lastname: Wu
authors.forename: He
authors.initials: H
authors.lastname: Yu
authors.forename: Nimisha
authors.initials: N
authors.lastname: Makan
authors.forename: Margaret R
authors.initials: MR
authors.lastname: Spitz
mesh_terms: D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide / Q000494:pharmacology; D001761:Bleomycin / Q000494:pharmacology; D002842:Chromatids / Q000473:pathology; D002869:Chromosome Aberrations; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006801:Humans; D018972:Insulin-Like Growth Factor Binding Protein 3 / Q000097:blood*; D007334:Insulin-Like Growth Factor I / Q000032:analysis*; D007335:Insulin-Like Growth Factor II / Q000032:analysis*; D008175:Lung Neoplasms / Q000097:blood* / Q000175:diagnosis; D008214:Lymphocytes / Q000187:drug effects / Q000378:metabolism; D009152:Mutagenicity Tests; D009153:Mutagens / Q000494:pharmacology*; D011237:Predictive Value of Tests; D012307:Risk Factors
chemical_list: D018972:Insulin-Like Growth Factor Binding Protein 3; D009153:Mutagens; D001761:Bleomycin; D015123:7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II